GeneWeave Biosciences has created a new and innovative platform for the surveillance and detection of infectious disease. Their proprietary GeneScout™ technology offers a truly transformational solution for health care providers seeking to detect and prevent infection from potentially life-threatening organisms.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/28/12 | $12,000,000 | Series A |
Claremont Creek Ventures Decheng Capital X/Seed Capital | undisclosed |
| 07/03/14 | $12,000,000 | Series B |
Claremont Creek Ventures Decheng Capital XSeed Capital | undisclosed |
